绝经后会发生什么(WHAM)?绝经前降低风险双侧输卵管卵巢切除术女性前瞻性对照研究的进展报告
WHAM研究是迄今规模最大的降低风险输卵管卵巢切除术(RRSO)前瞻性对照研究,纳入104例携带BRCA1/2致病突变的绝经前女性行RRSO及102例年龄匹配保留卵巢对照,随访24个月。已发表十余篇论文,关键发现包括RRSO对性功能、睡眠和情绪有不良影响,血管舒缩症状一般较轻、3个月达峰、24个月未加重,绝经激素治疗(MHT)可减轻但不解决血管舒缩症状,24个月骨密度丢失且MHT部分缓解,心脏代谢健康和认知基本维持。
要点
- RRSO对性功能、睡眠和情绪有不良影响,与对照女性相比。
- RRSO后血管舒缩症状一般较轻,3个月达峰,24个月未加重,MHT可减轻但不解决。
- 24个月观察到骨密度丢失,MHT部分缓解;心脏代谢健康和认知基本维持。
核心结论
- WHAM研究数据将增强手术绝经的循证照护,并支持围绕RRSO的共同决策,确保新证据快速转化为临床实践。
研究设计与样本
- WHAM为前瞻性对照研究,纳入104例携带BRCA1/2致病突变、行RRSO的绝经前女性和102例年龄匹配、保留卵巢的对照。
- 在基线与24个月之间测量性功能、血管舒缩症状、认知、情绪、心脏代谢健康和骨健康等结局,并评估RRSO后MHT使用情况及MHT对这些结局的影响。
- 试验注册:澳大利亚新西兰临床试验注册中心,注册号ACTRN12615000082505;anzctr.org.au。
主要发现
- 与对照女性相比,RRSO对性功能、睡眠和情绪有不良影响。
- RRSO后血管舒缩症状一般较轻,3个月达峰,24个月未加重;MHT可减轻但不解决血管舒缩症状。
- 24个月观察到骨密度丢失,MHT部分缓解;心脏代谢健康和认知在24个月基本维持。
临床怎么用
- 原文未据此给出推荐,仅指出这些独特数据将增强手术绝经的循证照护并支持围绕RRSO的共同决策。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Surgical menopause, the removal of both ovaries prior to natural menopause, may impact short-and long-term physical and emotional health. An increasingly common cause of surgical menopause is risk-reducing salpingo-oophorectomy (RRSO) in those at high inherited risk of ovarian cancer. The WHAM (What Happens After Menopause?) study is the largest prospective controlled study of RRSO. It measured the effect of RRSO compared to controls on physical and mental health over 2 years, and the potential modifying effects of menopausal hormone therapy (MHT). WHAM consists of 104 premenopausal women with BRCA1/2 pathogenic variants undergoing RRSO and 102 age-matched comparators who retained their ovaries. Outcomes including sexual function, vasomotor symptoms, cognition, mood, cardiometabolic health and bone health were measured between baseline and 24 months. MHT uptake after RRSO and the impact of MHT on these outcomes were assessed. Findings of WHAM have been published in more than ten manuscripts. Key findings include that RRSO adversely affects sexual function, sleep, and mood compared to comparison women. After RRSO, vasomotor symptoms (VMS) are generally mild, peak at 3 months, and do not worsen by 24 months. MHT reduces but does not resolve VMS. Loss of bone density was observed at 24 months and was partially mitigated by MHT. Cardiometabolic health and cognition were largely maintained at 24 months. This manuscript summarises the published findings of WHAM. These unique data will enhance evidence-based care in surgical menopause and will support shared decision-making around RRSO, ensuring rapid translation of new evidence into clinical practice. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry: registration no: ACTRN12615000082505; anzctr.org.au.
引用
- Price SAL, Maki PM, El Khoudary SR, et al. What Happens After Menopause (WHAM)? A Progress Report of a Prospective Controlled Study of Women After Pre-Menopausal Risk-Reducing Bilateral Salpingo-Oophorectomy. BJOG. 2025. PMID: 40697165. doi:10.1111/1471-0528.18304
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。